News Chart Bukwang Pharmaceutical Co., Ltd.

Equities

A003000

KR7003000007

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-04 pm EDT			5-day change	1st Jan Change
5,750 ^KRW	+0.17%		+1.59%	-5.74%

May. 14	Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion.	CI

e4f2cd467dc4aed2e232.c5CWVk9RMT5Mn15CP_iv3CvHAgZgfwyE9PvGOJsAvmk.KcT8HiULS1949CQNVaDeqGCsdnVTHTrBhJmAZ6k46y1e5KY3eigHRhrAbg~be2e62b4249938b1c61230bdeaf23acb